Walvax
Walvax
Yunnan Watson Biotechnology Co., Ltd. is a modern biopharmaceutical company specializing in the research and manufacture
Yunnan Watson Biotechnology Co., Ltd. is a modern biopharmaceutical company specializing in the research and manufacture The company was listed on the GEM Board of China Shenzhen Stock Exchange in November 2010 (stock abbreviation: Watson Bio; stock code: 300142).
- All
- News
- Analysis
- Research
Briefing Nov 29, 2021 06:24 PM
· Healthcare
Aibo biology completed the round C + financing of US $300 million
Briefing Nov 29, 2021 02:14 PM
· Healthcare
Yuanyin biology completed the pre-A round of financing of more than 100 million yuan
In depth
Healthcare
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
Briefing Nov 29, 2021 10:04 AM
· Healthcare
2021 Chinese hospital internet influence ranking list released 127 hospitals in 17 provinces and cities
Briefing Nov 21, 2021 05:59 PM
· Healthcare
Pakistan once again lifted the ban on tiktok
Apr 22, 2021 03:11 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Research
Real Estate, Industrials, FinancialsTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Briefing Nov 19, 2021 02:32 PM
· Healthcare
Yinming biological HPK1 small molecule inhibitor new drug has passed the United States ind, and the dry amd small molecule new drug has completed the phase I clinical trial in the United States
Briefing Nov 19, 2021 09:30 AM
· Healthcare
Tuochuang biology obtained more than 200 million yuan of round B financing to accelerate the development and clinical promotion of innovative antibody drugs
Briefing Nov 18, 2021 09:22 AM
· Healthcare
Lingtai biology completed the pre-A round of financing and is committed to the development of targeted protein degradation drugs
Briefing Sep 02, 2021 02:06 PM
· Healthcare
Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%
Insight
Briefing Jul 29, 2021 10:01 AM
Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%
Briefing Updated 2 hours ago
· Healthcare
The first phase I clinical trial of CSF-1R antibody drug in China was completed, and the first patient was administered
See more
Related Companies
EqualOcean Analysis
- Genetron Health's Self-Developed Mutation Capsule Differentiates It from Others
- Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
- China Speed: Two COVID-19 Vaccines Recognized by WHO
- After China's BNR and GTH Hit Nasdaq, Pan-Cancer Detector GRAIL Eyes IPO
- More Room for the Medical Device Market to Grow in China
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.